In-utero cannabis exposure and long-term psychiatric and neurodevelopmental outcomes: The limitations of existing literature and recommendations for future research
- PMID: 35708102
- PMCID: PMC9357094
- DOI: 10.1002/bdr2.2060
In-utero cannabis exposure and long-term psychiatric and neurodevelopmental outcomes: The limitations of existing literature and recommendations for future research
Abstract
Given increases in cannabis use in pregnancy and animal model research showing effects of in-utero cannabis exposure, high-quality information on long-term consequences of in-utero cannabis exposure in humans is needed. While reviews have summarized findings from observational studies with humans, reviews have not focused on limitations of these studies and recommendations for future research. Therefore, we critically reviewed observational research on in-utero cannabis exposure and psychiatric and neurodevelopmental outcomes measured at or after age 3 and provided recommendations for future research. We used Web of Science, Google Scholar, and work cited from relevant identified publications to identify 46 papers to include in our review. Our review includes two main sections. The first section highlights the extensive limitations of the existing research, which include small and nongeneralizable samples, reliance on self-reported data, lack of detail on timing and amount of exposure, inclusion of older exposure data only, not accounting for important confounders, inclusion of potential mediators as covariates, not including outcome severity measures, and not assessing for offspring sex differences. The second section provides recommendations for future research regarding exposure and outcome measures, sample selection, confounder adjustment, and other methodological considerations. For example, with regard to exposure definition, we recommend that studies quantify the amount of cannabis exposure, evaluate the influence of timing of exposure, and incorporate biological measures (e.g., urine toxicology measures). Given that high-quality information on long-term consequences of in-utero cannabis exposure in humans does not yet exit, it is crucial for future research to address the limitations we have identified.
Keywords: cannabis; marijuana; neurodevelopmental outcomes; pregnancy; prenatal exposure; psychiatric outcomes.
© 2022 Wiley Periodicals LLC.
Conflict of interest statement
Similar articles
-
A systematic review of in utero cannabis exposure and risk for structural birth defects.Front Pediatr. 2023 May 25;11:1149401. doi: 10.3389/fped.2023.1149401. eCollection 2023. Front Pediatr. 2023. PMID: 37303758 Free PMC article. Review.
-
An epidemiological, developmental and clinical overview of cannabis use during pregnancy.Prev Med. 2018 Nov;116:1-5. doi: 10.1016/j.ypmed.2018.08.036. Epub 2018 Aug 29. Prev Med. 2018. PMID: 30171964 Review.
-
Cannabis use during pregnancy and postpartum.Can Fam Physician. 2020 Feb;66(2):98-103. Can Fam Physician. 2020. PMID: 32060189 Free PMC article. Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Implications of Prenatal Cannabis Exposure on Childhood Neurodevelopmental Outcomes: A Summary of the Clinical Evidence.Obstet Gynecol Surv. 2024 Oct;79(10):604-610. doi: 10.1097/OGX.0000000000001320. Obstet Gynecol Surv. 2024. PMID: 39437378 Review.
Cited by
-
The unseen patient: competing priorities between patients and providers when cannabis is used in pregnancy, a qualitative study.Front Glob Womens Health. 2024 Apr 18;5:1355375. doi: 10.3389/fgwh.2024.1355375. eCollection 2024. Front Glob Womens Health. 2024. PMID: 38699460 Free PMC article.
-
Systematic review: the impact of maternal pre-and postnatal cannabis use on the behavioral and emotional regulation in early childhood.Eur Child Adolesc Psychiatry. 2025 Feb;34(2):423-463. doi: 10.1007/s00787-024-02494-8. Epub 2024 Jun 15. Eur Child Adolesc Psychiatry. 2025. PMID: 38878224 Free PMC article.
-
A systematic review of in utero cannabis exposure and risk for structural birth defects.Front Pediatr. 2023 May 25;11:1149401. doi: 10.3389/fped.2023.1149401. eCollection 2023. Front Pediatr. 2023. PMID: 37303758 Free PMC article. Review.
-
Association of cannabis use during pregnancy with severe acute respiratory syndrome coronavirus 2 infection: a retrospective cohort study.Addiction. 2023 Feb;118(2):317-326. doi: 10.1111/add.16056. Epub 2022 Oct 12. Addiction. 2023. PMID: 36189777 Free PMC article.
-
Prenatal Cannabis Use and Offspring Attention Deficit Hyperactivity Disorder and Disruptive Behavior Disorders: A Retrospective Cohort Study.J Dev Behav Pediatr. 2025 Jan-Feb 01;46(1):e25-e32. doi: 10.1097/DBP.0000000000001323. Epub 2024 Oct 15. J Dev Behav Pediatr. 2025. PMID: 39400201
References
-
- American College of Obstetricians and Gynecologist. (2017). Marijuana use during pregnancy and lactation: Committee Opinion No. 722. Obstetrics and Gynecology, 130, e205–209. https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinio... - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources